DARZALEX
These highlights do not include all the information needed to use DARZALEX safely and effectively. See full prescribing information for DARZALEX. DARZALEX (daratumumab) injection, for intravenous use Initial U.S. Approval: 2015
a4d0efe9-5e54-467e-9eb4-56fa7d53b60b
HUMAN PRESCRIPTION DRUG LABEL
Jan 22, 2024
Janssen Biotech, Inc.
DUNS: 099091753
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Daratumumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Daratumumab
Product Details
FDA regulatory identification and product classification information